American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$706M |
| 2 |
Kenvue
KVUE
|
+$193M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
+$160M |
| 4 |
Entegris
ENTG
|
+$160M |
| 5 |
Merck
MRK
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$301M |
| 2 |
Visa
V
|
+$269M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$217M |
| 4 |
Allstate
ALL
|
+$172M |
| 5 |
Air Products & Chemicals
APD
|
+$163M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.13% |
| 2 | Financials | 13.26% |
| 3 | Healthcare | 12.32% |
| 4 | Consumer Discretionary | 12.01% |
| 5 | Industrials | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Casella Waste Systems
CWST
$5.79B
| $1.05M | ﹤0.01% |
10,604
-3
| -0% | -$269 |
|
2127
Tetra Tech
TTEK
$9.33B
| $1.04M | ﹤0.01% |
28,280
+7,135
| +34% | +$247K |
|
2128
Q2 Holdings
QTWO
$4.13B
| $1.04M | ﹤0.01% |
19,869
-1,986
| -9% | -$89.8K |
|
2129
Arcosa
ACA
$7.12B
| $1.04M | ﹤0.01% |
12,110
| – | – |
|
2130
Prestige Consumer Healthcare
PBH
$2.43B
| $1.04M | ﹤0.01% |
14,307
+745
| +5% | +$49.8K |
|
2131
BGC Group
BGC
$5.2B
| $1.04M | ﹤0.01% |
133,575
-10,671
| -7% | -$79.1K |
|
2132
Caledonia Mining Corp
CMCL
$439M
| $1.04M | ﹤0.01% |
93,614
+22,947
| +32% | +$246K |
|
2133
Vanda Pharmaceuticals
VNDA
$304M
| $1.03M | ﹤0.01% |
251,238
+18,743
| +8% | +$75K |
|
2134
CareDx
CDNA
$2.45B
| $1.03M | ﹤0.01% |
97,198
+34,490
| +55% | +$345K |
|
2135
Park Aerospace
PKE
$811M
| $1.03M | ﹤0.01% |
61,849
-3,583
| -5% | -$53.2K |
|
2136
DraftKings
DKNG
$12.6B
| $1.03M | ﹤0.01% |
22,621
+42
| +0.2% | +$1.71K |
|
2137
Ducommun
DCO
$3.01B
| $1.02M | ﹤0.01% |
19,941
+5,915
| +42% | +$295K |
|
2138
Qiagen
QGEN
$8.93B
| $1.02M | ﹤0.01% |
23,114
+5,152
| +29% | +$235K |
|
2139
InMode
INMD
$875M
| $1.02M | ﹤0.01% |
47,229
-927,583
| -95% | -$20.7M |
|
2140
Janux Therapeutics
JANX
$978M
| $1.02M | ﹤0.01% |
27,055
+15,612
| +136% | +$340K |
|
2141
Clarus
CLAR
$145M
| $1.02M | ﹤0.01% |
150,751
+66,654
| +79% | +$411K |
|
|
GNTY
2142
DELISTED
Guaranty Bancshares
GNTY
| $1.02M | ﹤0.01% |
33,468
-100
| -0.3% | -$3.09K |
|
2143
Lincoln Educational Services
LINC
$955M
| $1.01M | ﹤0.01% |
98,050
+10,507
| +12% | +$102K |
|
2144
SSR Mining
SSRM
$6.49B
| $1.01M | ﹤0.01% |
227,072
-108,593
| -32% | -$757K |
|
|
VERV
2145
DELISTED
Verve Therapeutics
VERV
| $1.01M | ﹤0.01% |
75,975
+29,848
| +65% | +$396K |
|
2146
Calix
CALX
$2.51B
| $1.01M | ﹤0.01% |
30,388
+13,206
| +77% | +$492K |
|
2147
Oric Pharmaceuticals
ORIC
$1.42B
| $1.01M | ﹤0.01% |
73,167
+23,617
| +48% | +$280K |
|
2148
Clarivate
CLVT
$1.25B
| $1M | ﹤0.01% |
135,091
+24,721
| +22% | +$206K |
|
2149
Myriad Genetics
MYGN
$303M
| $1M | ﹤0.01% |
46,937
-104
| -0.2% | -$2.24K |
|
2150
TechTarget
TTGT
$277M
| $1,000K | ﹤0.01% |
30,224
+9,964
| +49% | +$328K |
|
Similar funds
American Century Companies's Q1 2024 Portfolio in Review
As of Q1 2024, American Century Companies held 2,999 positions worth $159B, up 9.4% from $145B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
American Century Companies's Q1 2024 filing shows 122 new, 1,903 increased, 717 reduced and 75 closed positions. Its largest new stake was Bombardier Recreational Products: 736,453 shares worth $49.4M. The largest sale was Nike, an estimated $301M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q1 2024 buy was Bombardier Recreational Products: 736,453 shares worth $49.4M.
- American Century Companies added most to Meta Platforms (Facebook) in Q1 2024, an estimated $706M increase.
- American Century Companies's biggest Q1 2024 reduction was Nike, cutting an estimated $301M.
- American Century Companies fully exited Mobileye in Q1 2024, selling an estimated $74.8M.
- American Century Companies's ten largest holdings make up 24% of its $159B portfolio in Q1 2024.
- American Century Companies opened 122 new positions and closed 75 in Q1 2024.
- American Century Companies's portfolio value rose 9.4% quarter-over-quarter to $159B.
Based on American Century Companies's 13F filing for Q1 2024, filed 14 May 2024.